➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Merck
Dow
Colorcon
Baxter

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LOFEXIDINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Lofexidine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000345 Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 Completed National Institute on Drug Abuse (NIDA) Phase 1 1996-04-01 The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.
NCT00000354 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 Completed University of Pennsylvania Phase 1 1996-07-01 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000354 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 Completed National Institute on Drug Abuse (NIDA) Phase 1 1996-07-01 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lofexidine Hydrochloride

Condition Name

Condition Name for Lofexidine Hydrochloride
Intervention Trials
Opioid-Related Disorders 6
Opioid Dependence 5
Opioid Withdrawal 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lofexidine Hydrochloride
Intervention Trials
Opioid-Related Disorders 9
Substance Withdrawal Syndrome 8
Substance-Related Disorders 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lofexidine Hydrochloride

Trials by Country

Trials by Country for Lofexidine Hydrochloride
Location Trials
United States 72
Singapore 1
Israel 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lofexidine Hydrochloride
Location Trials
Texas 9
New York 7
Pennsylvania 6
California 6
Utah 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lofexidine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Lofexidine Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 5
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lofexidine Hydrochloride
Clinical Trial Phase Trials
Completed 24
Not yet recruiting 5
Recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lofexidine Hydrochloride

Sponsor Name

Sponsor Name for Lofexidine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 23
US WorldMeds LLC 19
University of Pennsylvania 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lofexidine Hydrochloride
Sponsor Trials
NIH 23
Industry 20
Other 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Baxter
Medtronic
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.